$168.2M in CY2024 Part D spend1.1M claims · 515K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Insulin Glargine-Yfgn used for?
Insulin Glargine-Yfgn replaces or supplements natural insulin to control blood sugar in diabetes.
Is there a generic for Insulin Glargine-Yfgn?
No. Insulin Glargine-Yfgn is brand-only with no generic equivalents currently in market.
How much does my plan pay for Insulin Glargine-Yfgn?
Across 329 Part D plans, Insulin Glargine-Yfgn averages $11.59/unit (NADAC). Lowest available: $2.89/unit. Highest in distribution: $25.91/unit.
Is Insulin Glargine-Yfgn on the FDA shortage list?
No. Insulin Glargine-Yfgn is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (6 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.